These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17224473)

  • 1. Ala92 type 2 deiodinase allele increases risk for the development of hypertension.
    Gumieniak O; Perlstein TS; Williams JS; Hopkins PN; Brown NJ; Raby BA; Williams GH
    Hypertension; 2007 Mar; 49(3):461-6. PubMed ID: 17224473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological relevance of deiodinase polymorphism.
    Bianco AC; Kim BS
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):341-346. PubMed ID: 30063552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Type 2 Deiodinase Thr92Ala Polymorphism Is Associated with Higher Body Mass Index and Fasting Glucose Levels: A Systematic Review and Meta-Analysis.
    Wang X; Chen K; Zhang C; Wang H; Li J; Wang C; Teng W; Shan Z; Lai Y
    Biomed Res Int; 2021; 2021():9914009. PubMed ID: 34660805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Background Strongly Influences the Impact of Carrying the Thr92Ala-DIO2 Polymorphism in the Male Mouse.
    Gabriel de Almeida G; Bolin AP; Batistuzzo A; Fonseca TL; Ribeiro MO; Bianco AC
    Endocrinology; 2024 May; 165(7):. PubMed ID: 38836615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of thyroid function and polymorphisms in the type 2 deiodinase on blood pressure: the Rotterdam Study and the Rotterdam Scan Study.
    van der Deure WM; Peeters RP; Uitterlinden AG; Hofman A; Breteler MM; Witteman J; Visser TJ
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):137-44. PubMed ID: 19178511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects.
    Grarup N; Andersen MK; Andreasen CH; Albrechtsen A; Borch-Johnsen K; Jørgensen T; Auwerx J; Schmitz O; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2007 Jan; 92(1):363-6. PubMed ID: 17077128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain.
    Jo S; Fonseca TL; Bocco BMLC; Fernandes GW; McAninch EA; Bolin AP; Da Conceição RR; Werneck-de-Castro JP; Ignacio DL; Egri P; Németh D; Fekete C; Bernardi MM; Leitch VD; Mannan NS; Curry KF; Butterfield NC; Bassett JHD; Williams GR; Gereben B; Ribeiro MO; Bianco AC
    J Clin Invest; 2019 Jan; 129(1):230-245. PubMed ID: 30352046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes.
    McAninch EA; Jo S; Preite NZ; Farkas E; Mohácsik P; Fekete C; Egri P; Gereben B; Li Y; Deng Y; Patti ME; Zevenbergen C; Peeters RP; Mash DC; Bianco AC
    J Clin Endocrinol Metab; 2015 Mar; 100(3):920-33. PubMed ID: 25569702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between DIO2 Thr92Ala polymorphism and hypertension in patients with hypothyroidism: Korean Genome and Epidemiology Study.
    Kang YM; Koo BS; Yi HS; Kim JT; Park B; Lee JH; Shong M; Kang YE
    Korean J Intern Med; 2023 Mar; 38(2):226-237. PubMed ID: 36646987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor.
    Mentuccia D; Proietti-Pannunzi L; Tanner K; Bacci V; Pollin TI; Poehlman ET; Shuldiner AR; Celi FS
    Diabetes; 2002 Mar; 51(3):880-3. PubMed ID: 11872697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters.
    Peeters RP; van den Beld AW; Attalki H; Toor Hv; de Rijke YB; Kuiper GG; Lamberts SW; Janssen JA; Uitterlinden AG; Visser TJ
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E75-81. PubMed ID: 15727947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Thr92Ala deiodinase type 2 (DIO2) variant is not associated with type 2 diabetes or indices of insulin resistance in the old order of Amish.
    Mentuccia D; Thomas MJ; Coppotelli G; Reinhart LJ; Mitchell BD; Shuldiner AR; Celi FS
    Thyroid; 2005 Nov; 15(11):1223-7. PubMed ID: 16356084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 deiodinase Thr92Ala polymorphism is not associated with arterial hypertension in type 2 diabetes mellitus patients.
    Canani LH; Leie MA; Machado WE; Capp C; Maia AL
    Hypertension; 2007 Jun; 49(6):e47; author reply e48. PubMed ID: 17389255
    [No Abstract]   [Full Text] [Related]  

  • 14. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis.
    Heemstra KA; Hoftijzer HC; van der Deure WM; Peeters RP; Fliers E; Appelhof BC; Wiersinga WM; Corssmit EP; Visser TJ; Smit JW
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):279-83. PubMed ID: 19018782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis.
    Dora JM; Machado WE; Rheinheimer J; Crispim D; Maia AL
    Eur J Endocrinol; 2010 Sep; 163(3):427-34. PubMed ID: 20566590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of 19 functional polymorphisms in iodothyronine deiodinase and psychological well-being in hypothyroid patients.
    Young Cho Y; Jeong Kim H; Won Jang H; Hyuk Kim T; Ki CS; Wook Kim S; Hoon Chung J
    Endocrine; 2017 Jul; 57(1):115-124. PubMed ID: 28466400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 deiodinase Thr92Ala polymorphism is associated with disrupted placental activity but not with dysglycemia or adverse gestational outcomes: a genetic association study.
    Dora JM; Wajner SM; Costa JD; Pinto Ribeiro RV; Leiria LB; Lopes MG; Vitali da Silva A; Crispim D; Maia AL
    Fertil Steril; 2014 Mar; 101(3):833-9. PubMed ID: 24355051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D2-Thr92Ala, thyroid hormone levels and biochemical hypothyroidism in preeclampsia.
    Procopciuc LM; Caracostea G; Hazi G; Nemeti G; Stamatian F
    Gynecol Endocrinol; 2017 Feb; 33(2):136-140. PubMed ID: 27809617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients.
    Torlontano M; Durante C; Torrente I; Crocetti U; Augello G; Ronga G; Montesano T; Travascio L; Verrienti A; Bruno R; Santini S; D'Arcangelo P; Dallapiccola B; Filetti S; Trischitta V
    J Clin Endocrinol Metab; 2008 Mar; 93(3):910-3. PubMed ID: 18073314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe.
    de Jong FJ; Peeters RP; den Heijer T; van der Deure WM; Hofman A; Uitterlinden AG; Visser TJ; Breteler MM
    J Clin Endocrinol Metab; 2007 Feb; 92(2):636-40. PubMed ID: 17105838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.